朴炳奎治疗肿瘤常用药组探析
Analysis of Professor PIAO Bingkui's Commonly Used Drug Groups in Treating Tumors
DOI:10.13288/j.11-2166/r.2021.16.004
扫 描 看 全 文
1.中国中医科学院广安门医院,北京市西城区北线阁5号,100053
扫 描 看 全 文
张孝刚, 胡帅航, 田培裕, 等. 朴炳奎治疗肿瘤常用药组探析[DB/OL].(2021-11-02)[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails#10.13288/j.11-2166/r.2021.16.004
ZHANG Xiaogang, HU Shuaihang, TIAN Peiyu, et al. Analysis of Professor PIAO Bingkui's Commonly Used Drug Groups in Treating Tumors[DB/OL].(2021-11-02)[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails#10.13288/j.11-2166/r.2021.16.004
张孝刚, 胡帅航, 田培裕, 等. 朴炳奎治疗肿瘤常用药组探析[DB/OL].(2021-11-02)[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails#10.13288/j.11-2166/r.2021.16.004 DOI:
ZHANG Xiaogang, HU Shuaihang, TIAN Peiyu, et al. Analysis of Professor PIAO Bingkui's Commonly Used Drug Groups in Treating Tumors[DB/OL].(2021-11-02)[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails#10.13288/j.11-2166/r.2021.16.004 DOI:
总结朴炳奎教授治疗肿瘤的常用药组,探讨其临证思路及学术观点。认为肿瘤核心病机为虚实两端,正气虚是肿瘤发病基础,临证强调扶正培本在肿瘤中医治疗中的核心地位,从而形成黄芪、当归、女贞子、枸杞子扶正培本药组,陈皮、炒山楂、炒神曲、炒麦芽护胃运脾药组;并充分考虑肿瘤特性及各脏腑生理特点,针对不同部位的肿瘤亦形成药组,如沙参、桔梗、麦冬、苦杏仁为治疗肺癌药组,急性子、白花蛇舌草、土茯苓、莪术为治疗食管癌药组,白术、山药、枳壳、益智仁为治疗胃癌、结直肠癌药组,北柴胡、白芍、枳壳、甘草为治疗卵巢癌、乳腺癌药组,威灵仙、续断、牛膝、骨碎补治疗骨肿瘤药组,天冬、赤芍、玄参、北沙参为治疗鼻咽癌药组。
This paper summarized professor PIAO Bingkui's commonly used drug groups in treating tumors, and discussed his thoughts in clinical practice and academic researches. It is believed that the core disease mechanism of tumor should be considered as two aspects, deficiency and excess, and healthy ,qi, deficiency is the basis of tumor pathogenesis. Therefore, reinforcing healthy ,qi, and fostering the root is considered as the core treatment principle in clinical practice, and correspondingly drug groups are formulated including Huangqi (,Radix Astragali,), Danggui (,Radix Angelicae Sinensis,), Nuzhenzi (,Fructus Ligustri Lucidi,), Gouqizi (,Fructus Lycii,) to reinforce healthy ,qi, and foster root, as well as Chenpi (,Pericarpium Citri Reticulatae,), Chaoshanzha (fried ,Fructus Crataegi,), Chaoshenqu (fried ,Massa Medicata Fermentata,), and Chaomaiya (dried ,Fructus Hordei Germinatus,) to protect stomach and activate spleen. Simultaneously, the drug groups target to tumors in different parts can be developed after fully considering the tumor specifics and the physiological characteristics of related ,zang-fu, organs (脏腑), such as the drug group of Shashen (,Radix Adenophorae seu Glehniae,), Jiegeng (,Radix Platycodonis,), Maidong (,Radix Ophiopogonis,) and Kuxinren (,Semen Armeniacae Amarum,) for lung cancer; the group of Jixingzi (,Semen Impatientis,), Baihua Sheshe Cao (,Herba Hedyotis Diffusae,), Tufuling (,Rhizoma Smilacis Glabrae,) and Ezhu (,Rhizoma Curcumae,) for esophageal cancer; the group of Baizhu (,Rhizoma Atractylodis Macrocephalae,), Shanyao (,Rhizoma Dioscoreae,), Zhiqiao (,Fructus Aurantii,) and Yizhiren (,Fructus Alpiniae Oxyphyllae,) for stomach cancer and colorectal cancer; the drug group of Beichaihu (,Bupleurum chinense DC.,), Baishao (,Radix Paeoniae Alba,), Zhiqiao and Gancao (,Radix et Rhizoma Glycyrrhizae,) for ovarian cancer and breast cancer; the drug group of Weilingxian (,Radix et Rhizoma Clematidis,), Xuduan (,Radix Dipsaci,), Niuxi (,Radix Achyranthis Bidentatae,) and Gusuibu (,Rhizoma Drynariae,) for bone tumor; and the group of Tiandong (,Radix Asparagi,), Chaishao (,Radix Paeoniae Rubra,), Xuanshen (,Radix Scrophulariae,) and Beishashen (,Radix Glehniae,) for nasopharyngeal carcinoma.
肿瘤药组名医经验朴炳奎
tumorsdrug groupsexperience of famous doctor'sPIAO Bingkui
王振兴, 潘怡, 张秀, 等. 邓中甲治疗肝系病证常用药组选析[J]. 辽宁中医杂志, 2017, 44(7): 1377-1379.
高荣林, 姜在旸. 中国中医研究院广安门医院专家医案精选[M]. 北京: 金盾出版社, 2005: 590.
裴慧, 雷静, 钱士辉. 一个从急性子中分离得到的新的具有细胞毒活性的双萘呋喃-7, 12-酮类衍生物(英文)[J]. 中药材, 2012, 35(3): 407-410.
程孟祺, 胡佳奇, 赵雨薇, 等. 基于网络药理学的威灵仙-急性子药对治疗食管癌的机制研究[J]. 海南医学院学报, 2021, 27(1): 52-60.
尤在泾. 金匮要略心典[M]. 北京: 北京科学技术出版社, 2016: 36.
张介宾. 景岳全书[M]. 上海: 第二军医大学出版社, 2006: 480.
乔红丽, 侯炜, 郑红刚, 等. 朴炳奎教授辨治大肠癌经验探析[J]. 中医学报, 2014, 29(2): 168-170.
林飞. 朴炳奎调补脾肾法治疗胃癌学术经验[J]. 北京中医药, 2017, 36(1): 49-50,53.
李佳圆. 中国乳腺癌危险因素研究现况及其风险预测模型研究展望[J]. 中国循证医学杂志, 2020, 20(7): 745-748.
赵文华, 宋静慧. 卵巢癌危险因素研究进展[J]. 国际妇产科学杂志, 2013, 40(1): 50-53.
杨武斌, 罗晓玲, 胡娟, 等. 紫草抗肿瘤活性成分及作用机制研究现状[J]. 解放军药学学报, 2017, 33(4): 359-362.
王兵, 赵彪, 侯炜, 等. 朴炳奎辨治脑瘤经验[J]. 中医杂志, 2013, 54(17): 1455-1457.
张盼盼, 贾伟, 焦方文, 等. 全蝎蛋白抗肿瘤活性研究[J]. 中南药学, 2017, 15(8): 1069-1071.
朱宏, 梁良. 全蝎组织提取物抗肿瘤活性的研究[J]. 中华中医药学刊, 2014, 32(12): 3039-3041.
潘宏宇, 陈培丰. 虫类药抗肿瘤作用研究现状[J]. 浙江中西医结合杂志, 2017, 27(4): 352-356.
王兵, 赵彪, 乔红丽, 等. 朴炳奎教授治疗鼻咽癌验案一则[J]. 浙江中医药大学学报, 2013, 37(10): 1187-1188.
王艳杰, 康芯荣, 张雨薇, 等. 当归补血汤抗肿瘤作用研究进展[J]. 中国医学装备, 2017, 14(8): 165-169.
李闪闪, 魏丹丹, 蒋士卿. 基于藏象理论探讨化疗药的药物毒性[J]. 中国实验方剂学杂志, 2021, 26(5): 198-205.
0
浏览量
12
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构